Is the future of liver disease treatment about to change?

The latest episode of the DDW 'In Conversation With' series is available to listen to below.

This week, Bruno Quinney speaks to Amir Hefni, CEO of Resolution Therapeutics. Resolution specialises in developing therapies for inflammatory and fibrotic diseases and is currently progressing a treatment for end-stage liver disease through clinical trial.

Bruno spoke to Amir about how Resolution's therapy is addressing a critical unmet need and how long it could be before we see it available to patients. 

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.